156 related articles for article (PubMed ID: 1708746)
21. Minireview: Fibronectin in retinal disease.
Miller CG; Budoff G; Prenner JL; Schwarzbauer JE
Exp Biol Med (Maywood); 2017 Jan; 242(1):1-7. PubMed ID: 27798121
[TBL] [Abstract][Full Text] [Related]
22. Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy.
Fredj-Reygrobellet D; Baudouin C; Nègre F; Caruelle JP; Gastaud P; Lapalus P
Ophthalmic Res; 1991; 23(3):154-61. PubMed ID: 1719460
[TBL] [Abstract][Full Text] [Related]
23. Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation.
Singer II; Scott S; Kawka DW; Kazazis DM; Gailit J; Ruoslahti E
J Cell Biol; 1988 Jun; 106(6):2171-82. PubMed ID: 2454933
[TBL] [Abstract][Full Text] [Related]
24. [Role of macrophages and fibronectin in vitreoretinal proliferation].
Weller M; Heimann K; Wiedemann P
J Fr Ophtalmol; 1988; 11(3):243-7. PubMed ID: 3047202
[TBL] [Abstract][Full Text] [Related]
25. Expression of integrins in human proliferative diabetic retinopathy membranes.
Ning A; Cui J; Maberley D; Ma P; Matsubara J
Can J Ophthalmol; 2008 Dec; 43(6):683-8. PubMed ID: 19020635
[TBL] [Abstract][Full Text] [Related]
26. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
27. Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins.
Bauer JS; Schreiner CL; Giancotti FG; Ruoslahti E; Juliano RL
J Cell Biol; 1992 Jan; 116(2):477-87. PubMed ID: 1370495
[TBL] [Abstract][Full Text] [Related]
28. Iron-binding proteins in the human vitreous: lactoferrin and transferrin in health and in proliferative intraocular disorders.
Weller M; Clausen R; Heimann K; Wiedemann P
Ophthalmic Res; 1990; 22(3):194-200. PubMed ID: 2385435
[TBL] [Abstract][Full Text] [Related]
29. uPA, tPA and PAI-1 mRNA expression in periretinal membranes.
Sirén V; Immonen I
Curr Eye Res; 2003 Nov; 27(5):261-7. PubMed ID: 14562162
[TBL] [Abstract][Full Text] [Related]
30. The extracellular matrix of reparative tissue in the vitreous: fibronectin production in proliferative diabetic retinopathy membranes.
Hiscott P; Waller HA; Grierson I; Butler MG; Scott DL
Eye (Lond); 1993; 7 ( Pt 2)():288-92. PubMed ID: 7607348
[TBL] [Abstract][Full Text] [Related]
31. The significance of fibronectin in vitreoretinal pathology. A critical evaluation.
Weller M; Wiedemann P; Heimann K; Zilles K
Graefes Arch Clin Exp Ophthalmol; 1988; 226(3):294-8. PubMed ID: 3402754
[TBL] [Abstract][Full Text] [Related]
32. Proteins of the extracellular matrix in vitreoretinal membranes.
Scheiffarth OF; Kampik A; Günther H; von der Mark K
Graefes Arch Clin Exp Ophthalmol; 1988; 226(4):357-61. PubMed ID: 3049258
[TBL] [Abstract][Full Text] [Related]
33. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
34. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
[TBL] [Abstract][Full Text] [Related]
35. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
36. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.
Heidenkummer HP; Kampik A; Petrovski B
Retina; 1992; 12(1):52-8. PubMed ID: 1565872
[TBL] [Abstract][Full Text] [Related]
37. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
Weller M; Esser P; Heimann K; Wiedemann P
Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
[TBL] [Abstract][Full Text] [Related]
38. An immunochemical quantitative analysis of the protein pattern in physiologic and pathologic vitreous.
Clausen R; Weller M; Wiedemann P; Heimann K; Hilgers RD; Zilles K
Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):186-90. PubMed ID: 2044983
[TBL] [Abstract][Full Text] [Related]
39. The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis.
Weller M; Heimann K; Wiedemann P
Med Hypotheses; 1990 Feb; 31(2):157-9. PubMed ID: 2325589
[TBL] [Abstract][Full Text] [Related]
40. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
